BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eshel R, Neumark E, Sagi-assif O, Witz IP. Receptors involved in microenvironment-driven molecular evolution of cancer cells. Seminars in Cancer Biology 2002;12:139-47. [DOI: 10.1006/scbi.2001.0422] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Sajti E, Kavelaars A, Meeteren NV, Teunis M, Gispen WH, Heijnen C. Tumor angiogenesis and metastasis formation are associated with individual differences in behavior of inbred Lewis rats. Brain, Behavior, and Immunity 2004;18:497-504. [DOI: 10.1016/j.bbi.2003.11.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
2 Aychek T, Miller K, Sagi-assif O, Levy-nissenbaum O, Israeli-amit M, Pasmanik-chor M, Jacob-hirsch J, Amariglio N, Rechavi G, Witz IP. E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release. Int J Cancer 2008;123:1741-50. [DOI: 10.1002/ijc.23375] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lang MA, Jenkins SA, Balzano P, Owoyele A, Patel A, Bamezai AK. Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4+ T-cell lines. Immun Inflamm Dis 2017;5:448-60. [PMID: 28660664 DOI: 10.1002/iid3.182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
4 Witz IP. Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res. 2008;100:203-229. [PMID: 18620097 DOI: 10.1016/s0065-230x(08)00007-9] [Cited by in Crossref: 86] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
5 Yang X, Liu F, Xu Z, Chen C, Wu X, Li G, Li J. Expression of granulocyte colony stimulating factor receptor in human colorectal cancer. Postgrad Med J. 2005;81:333-337. [PMID: 15879049 DOI: 10.1136/pgmj.2004.024646] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
6 Witz IP, Levy-Nissenbaum O. The tumor microenvironment in the post-PAGET era. Cancer Lett. 2006;242:1-10. [PMID: 16413116 DOI: 10.1016/j.canlet.2005.12.005] [Cited by in Crossref: 94] [Cited by in F6Publishing: 85] [Article Influence: 5.9] [Reference Citation Analysis]
7 Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene 2009;28:3307-19. [PMID: 19597465 DOI: 10.1038/onc.2009.181] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
8 Levy-Nissenbaum O. Milestones in the field of tumor microenvironment--contributions & perspectives of Prof. Isaac P. Witz. Cancer Metastasis Rev 2005;24:469-72. [PMID: 16258732 DOI: 10.1007/s10555-005-5136-1] [Reference Citation Analysis]
9 Witz IP. Tumor-Microenvironment Interactions. In: Dalgleish AG, Haefner B, editors. The Link Between Inflammation and Cancer. Boston: Springer US; 2006. pp. 125-40. [DOI: 10.1007/0-387-26283-0_6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
10 Williams EL, Lim SH, Beers SA, Johnson PW, Strefford JC, Glennie MJ, Cragg MS. Overcoming Resistance to Therapeutic Antibodies by Targeting Fc Receptors. In: Bonavida B, editor. Resistance to Immunotherapeutic Antibodies in Cancer. New York: Springer; 2013. pp. 49-71. [DOI: 10.1007/978-1-4614-7654-2_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]